Journals / Bozok Tıp Dergisi / 2015 / Cilt: 5 - Sayı: 3

Hepatitis B and Hepatitis C Seropositivity Rates in Pregnants who Live in Kırıkkale Region.

KIRIKKALE BÖLGESİNDE YAŞAYAN GEBELERDE HEPATİT B ve HEPATİT C SEROPOZİTİFLİK ORANLARI

Pages
1–4
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

HBs Ag positivity rates were higher in patients over the age of 30 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of our study was determine the seroprevalence of HBsAg, Anti-HBs, Anti-HCV in pregnant women living in Kırıkkale city.
📊
Key Findings & Data:Material and Methods: HBsAg, Anti-HBs and Anti-HCV results of the pregnant women that admitted to the obstetrics and gynecology clinics between June 2012 and June 2014 were retrospectively investigated. 8442 pregnant women for HBsAg serology , 3094 pregnant women for Anti HBS serology, 8120 pregnant women for Anti-HCV were examined.
💡
Conclusion & Impact:HBs Ag positivity rates were higher in patients over the age of 30 (p
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of our study was determine the seroprevalence of HBsAg, Anti-HBs, Anti-HCV in pregnant women living in Kırıkkale city. Material and Methods: HBsAg, Anti-HBs and Anti-HCV results of the pregnant women that admitted to the obstetrics and gynecology clinics between June 2012 and June 2014 were retrospectively investigated. 8442 pregnant women for HBsAg serology , 3094 pregnant women for Anti HBS serology, 8120 pregnant women for Anti-HCV were examined. Patients aged 18-30 years and 30 were divided into two groups and seropositivity rates of the two groups were compared. HBsAg, Anti-HBs and Anti-HCV levels by ELISA method has been studied in Kirikkale University School of Medicine, Infectious Diseases and Clinical Microbiology laboratory. Results: HBsAg positivity were 2.34% in the 18-30 age group and were 4,79% in the above 30 years group; Anti HBs positivity were 58,51% in the 18-30 age group and were 29,6% in the above 30 years group; Anti-HCV positivity were 0,31% in the 18-30 age group and were 0,59% in the above 30 years group. HBs Ag positivity rates were higher in patients over the age of 30 (p

Özet

ÖZET Amaç: Bu çalışmada Kırıkkale bölgesinde yaşayan gebelerde HBsAg, Anti-HBs, Anti-HCV pozitiflik oranlarını belirlemeyi amaçladık. Gereç ve Yöntemler: Çalışmaya Haziran 2012-Haziran 2014 tarihleri arasında Kırıkkale Üniversitesi Tıp Fakül- tesi Kadın Hastalıkları ve Doğum polikliniğine gebelik takibi nedeniyle başvuran gebelerden HBsAg, Anti-HBs, Anti-HCV sonuçlarına ulaşılabilen hastalar dahil edildi. HBsAg serolojisi yönünden 8442, Anti HBS serolojisi yönünden 3094, Anti-HCV serolojisi yönünden 8120 gebe değerlendirilmiştir. Hastalar 18-30 yaş ve 30 yaş üstü olarak iki gruba ayrılmış olup her iki grubun seropozitiflik oranları karşılaştırılmıştır. Hastalarda HBsAg, Anti-HBs Anti-HCV düzeyleri ELİSA yöntemi ile Kırıkkale Üniversitesi Tıp Fakültesi Enfeksiyon Hastalıkları ve Klinik Mikro- biyoloji laboratuarında çalışılmıştır. Bulgular: Seropozitiflik oranları 18-30 yaş arasında HBsAg için %2,34, 30 yaş üzerinde %4,79, Anti HBs için 18- 30 yaş arası %58,51, 30 yaş üzerinde %29,6, Anti-HCV için 18-30 yaş arası %0,31, 30 yaş üzerinde %0,59 olarak hesaplanmıştır. HBs Ag pozitiflik oranı 30 yaş üstü grupta, 18-30 yaş arası gruba oranla anlamlı olarak daha yüksek (p

🔖

Cite This Article

GÜL, S., TULMAÇ, Ö. B., DAĞ, Z. Ö., ŞİMŞEK, Y., IŞIK, Y. (2022). Hepatitis B and Hepatitis C Seropositivity Rates in Pregnants who Live in Kırıkkale Region.. Bozok Tıp Dergisi, Cilt: 5 - Sayı: 3, 1–4. https://ajindex.com/articles/468857

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev. 2000; 64(1): 51-68
  2. Chisari FV, Ferrari C, Mondelli MU. Hepatitis B virus structure and biology. Microb Pathog. 1989;6(5): 311-25
  3. World Health Organization. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 1999;6(1): 35-47
  4. Elinav E, Ben-Dov IZ, Shapira Y, Daudi N, Adler R, Shouval D et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology. 2006;130(4): 1129-34
  5. Ornoy A, Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol. 2006; 21(4):446-457
  6. Lu Y, Chen Y, Xiao X, Liang X, Li J, Huang S et al. [Impact of maternal hepatitis B surface antigen carrier status on preterm delivery in southern China]. Nan Fang Yi Ke Da Xue Xue Bao. 2012;32(9):1369-72
  7. World Health Organisation: Hepatitis B: World Health Organisation factsheet 204 (Revised July 2012). Available at ttp://www.who.int/mediacentre/factsheets/fs204/en/ (last accessed 7th Sept 2013)
  8. Edmunds, Medley GF, Nokes DJ, Hall AJ, Whittle HC: The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci. 1993, 253(1337):197–201
  9. Dienstag JL. Chronic viral hepatitis. In: Mandell GL, Bennet Je, Dolin R (eds). Mandel Douglas and Bennets Principles and Practice of Infectious Diseases. 6th ed. Phledalphia: Churchill Livingstone, 2005:1441-64
  10. Mıstık R. Türkiyede viral hepatit epidemiyolojisi. Tabak F, Balık İ, Tekeli E (eds). Viral Hepatit 2007
  11. Baskı. İstanbul: Viral Hepatitle Savaşım Derneği, 2007: 10-50
  12. Kuru Ü, Turan Ö, Ceylan Y, Nurluoglu M, Önür C, Ağaçfidan A et al. (İncidence of HBsAg positivity in pregnancy). Klimik Derg. 1992;5(2):83-6
  13. Kadanalı A, Çelebi S, Aydos SK, Kadanalı S, Ayyıldız A. (Perinatal Transmission of Hepatit B virus in Erzurum). AÜTD. 1997;29(2):450-2
  14. Gül A, Türkdoğan MK, Zeteroğlu Ş. (The prevalance of Hepatit B and Hepatit C in a group of pregnant women). Perinatoloji Dergisi. 1998;6(3-4):67-9
  15. Biri A, Kılıç G, Bozdayı G, Tezcan S. Prevalance of Hepatitis B, Hepatitis C and Human immundeficiency Viruses during Pregnancy. T Klin J Med Res. 2001;19(2):100-103
  16. Uyar Y, Cabar C, Balci A. Seroprevalence of Hepatitis B Virus among preg